139 related articles for article (PubMed ID: 18855683)
21. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.
White ES; Lazar MH; Thannickal VJ
J Pathol; 2003 Nov; 201(3):343-54. PubMed ID: 14595745
[TBL] [Abstract][Full Text] [Related]
22. Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis.
Antoniou KM; Pataka A; Bouros D; Siafakas NM
Pulm Pharmacol Ther; 2007; 20(5):453-61. PubMed ID: 16516512
[TBL] [Abstract][Full Text] [Related]
23. Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis.
Chen H; Qu J; Huang X; Kurundkar A; Zhu L; Yang N; Venado A; Ding Q; Liu G; Antony VB; Thannickal VJ; Zhou Y
Nat Commun; 2016 Aug; 7():12564. PubMed ID: 27535718
[TBL] [Abstract][Full Text] [Related]
24. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
Mizuno S; Matsumoto K; Li MY; Nakamura T
FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
[TBL] [Abstract][Full Text] [Related]
25. BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts.
Kuehl T; Lagares D
Matrix Biol; 2018 Aug; 68-69():94-105. PubMed ID: 29408011
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
Im J; Kim K; Hergert P; Nho RS
J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
[TBL] [Abstract][Full Text] [Related]
27. Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways.
Nie Y; Yang Y; Zhang J; Cai G; Chang Y; Chai G; Guo C
Biomed Pharmacother; 2017 Nov; 95():1119-1128. PubMed ID: 28922731
[TBL] [Abstract][Full Text] [Related]
28. Classical transient receptor potential 6 (TRPC6) channels support myofibroblast differentiation and development of experimental pulmonary fibrosis.
Hofmann K; Fiedler S; Vierkotten S; Weber J; Klee S; Jia J; Zwickenpflug W; Flockerzi V; Storch U; Yildirim AÖ; Gudermann T; Königshoff M; Dietrich A
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):560-568. PubMed ID: 27932059
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
[TBL] [Abstract][Full Text] [Related]
30. Expression of bcl-2 protein and APO-1 (Fas antigen) in the lung tissue from patients with idiopathic pulmonary fibrosis.
Kazufumi M; Sonoko N; Masanori K; Takateru I; Akira O
Microsc Res Tech; 1997 Sep; 38(5):480-7. PubMed ID: 9376651
[TBL] [Abstract][Full Text] [Related]
31. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
Andersson-Sjöland A; de Alba CG; Nihlberg K; Becerril C; Ramírez R; Pardo A; Westergren-Thorsson G; Selman M
Int J Biochem Cell Biol; 2008; 40(10):2129-40. PubMed ID: 18374622
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol inhibits transforming growth factor-β-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration.
Fagone E; Conte E; Gili E; Fruciano M; Pistorio MP; Lo Furno D; Giuffrida R; Crimi N; Vancheri C
Exp Lung Res; 2011 Apr; 37(3):162-74. PubMed ID: 21269063
[TBL] [Abstract][Full Text] [Related]
33. The role of the adenosinergic system in lung fibrosis.
Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
[TBL] [Abstract][Full Text] [Related]
34. Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli.
Dodi AE; Ajayi IO; Chang C; Beard M; Ashley SL; Huang SK; Thannickal VJ; Tschumperlin DJ; Sisson TH; Horowitz JC
Respir Res; 2018 May; 19(1):91. PubMed ID: 29747634
[TBL] [Abstract][Full Text] [Related]
35. miR-542-5p Attenuates Fibroblast Activation by Targeting Integrin α6 in Silica-Induced Pulmonary Fibrosis.
Yuan J; Li P; Pan H; Li Y; Xu Q; Xu T; Ji X; Liu Y; Yao W; Han L; Ni C
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467286
[TBL] [Abstract][Full Text] [Related]
36. Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis.
Semren N; Habel-Ungewitter NC; Fernandez IE; Königshoff M; Eickelberg O; Stöger T; Meiners S
PLoS One; 2015; 10(9):e0136188. PubMed ID: 26340365
[TBL] [Abstract][Full Text] [Related]
37. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
38. Epithelial cell apoptosis by fas ligand-positive myofibroblasts in lung fibrosis.
Golan-Gerstl R; Wallach-Dayan SB; Amir G; Breuer R
Am J Respir Cell Mol Biol; 2007 Mar; 36(3):270-5. PubMed ID: 16990614
[TBL] [Abstract][Full Text] [Related]
39. Contribution of Fetal, but Not Adult, Pulmonary Mesothelium to Mesenchymal Lineages in Lung Homeostasis and Fibrosis.
von Gise A; Stevens SM; Honor LB; Oh JH; Gao C; Zhou B; Pu WT
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):222-30. PubMed ID: 26121126
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor in lung repair and pulmonary fibrosis.
Panganiban RA; Day RM
Acta Pharmacol Sin; 2011 Jan; 32(1):12-20. PubMed ID: 21131996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
